Control de factores de riesgo y tratamiento de la aterotrombosis. Registro REACH España

Suárez, Carmen; Cairols, Marc; Castillo, José; Esmatjes, Enric; Sala, Joan; Llobet, X.; Palma, Juan Carlos

doi:10.1016/s0025-7753(07)72882-8

Cited by 36 publications

(12 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…20 For Spanish patients with established cardiovascular disease, the prevalence of MS is 37%, 21,22 which is also lower than the rate measured in our study. This could be due to the fact that patients with PAD have a greater burden of risk factors than patients who have ischemic heart disease or cerebrovascular disease (as revealed in the REACH study 23 ). It could also be due to the fact that diabetes, a disease closely linked to MS, is intimately related to PAD.…”

Section: Discussionmentioning

confidence: 99%

Metabolic syndrome in patients with peripheral arterial disease

Estirado

Lahoz

Laguna

et al. 2014

Revista Clínica Española (English Edition)

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Metabolic syndrome in patients with peripheral arterial disease

Estirado

Lahoz

Laguna

et al. 2014

Revista Clínica Española (English Edition)

View full text Add to dashboard Cite

“…On the other hand, our data did not support those from the REACH study. 2 The cerebrovascular disease subgroup in REACH showed higher prevalence of HTN (74.8%), smoking (54.8%), and high cholesterol (50.3%), although the prevalence of type-2 DM was somewhat lower (37.2%).…”

Section: Discussionmentioning

confidence: 87%

“…There were 124 126 deaths due to cardiovascular disease compared to 103 329 due to neoplasia during that year. 1 Few studies in our country have examined adherence to secondary prevention measures for cerebrovascular disease, [2][3][4] while other topics in atherothrombosis, such as ischaemic heart disease, have received more attention. Regarding secondary prevention for cardiovascular disease, the literature 2 reports that only 43% of patients have well-controlled blood pressure, while 51.8% have cholesterol levels within the recommended range and 70% have good blood sugar levels.…”

Section: Introductionmentioning

confidence: 99%

“…Studies of treatment prescribed to patients with acute ischaemic stroke 2,3 reveal that 77% to 83% of these patients are treated with antiplatelet drugs while 17% to 18% are on anticoagulants; statin drugs are prescribed to 11% to 52%. 2,4 In 2008, the Ministry of Health published clinical practice guidelines (CPG) for primary and secondary stroke prevention. 5 For patients who are stable after having suffered ischaemic stroke or transient ischaemic attack (TIA), the guidelines recommend gradually decreasing blood pressure to reach a target of 130/80 mm Hg (grade B recommendation).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Implementation of clinical practice guidelines for acute ischaemic stroke in specialist care centres

Pardo-Cabello¹,

Conde²,

Gamero³

et al. 2013

Neurología (English Edition)

View full text Add to dashboard Cite

Introduction: Cerebrovascular disease is associated with high morbidity and mortality. In 2008, the Spanish Ministry of Health published its Clinical Practice Guidelines for stroke prevention, but implementation of that document has not yet been assessed. Our study aims to investigate compliance with the Guidelines by analysing control over vascular risk factors, antithrombotic treatment and lipid lowering treatment in patients who had suffered an acute ischaemic stroke and who were under the care of neurologists or internists.Methods: Cross-sectional study based on data from clinical reports (vascular risk factors, diagnosis and treatment), blood pressure readings and laboratory tests pertaining to 203 patients diagnosed with acute ischaemic stroke and admitted to a medium-to-long stay hospital for rehabilitation and care.Results: The mean patient age was 75 ± 10 years; 56% were women. The most common risk factors were hypertension (68%) and diabetes mellitus (40%). Intravenous fibrinolytic therapy had been administered to 8.9% of the patients. Of the patients with thrombotic cerebral infarction, 91.7% received antiplatelet agents; 59.4% of patients with embolic infarction received anticoagulants. Statins were prescribed to 65% of patients with thrombotic infarction. Laboratory tests upon admission showed that 23% of patients had total cholesterol levels above 175 mg/dl and 26.6% had plasma glucose levels above 126 mg/dl. Of the patient total, 70% received antihypertensive therapy, but 47.5% had blood pressure levels above 130/80 mm Hg.Conclusions: In our opinion, secondary prevention of acute cerebrovascular disease could be improved, mainly by increasing the percentage of patients treated with antiplatelet or anticoagulant drugs (depending on aetiology), increasing prescription of statins, and improving blood pressure control. Implementación de las guías de práctica clínica sobre ictus isquémico agudo en atención especializada Resumen Introducción: La enfermedad cerebrovascular se asocia a una elevada morbimortalidad. En el año 2008, el Ministerio de Sanidad publicó la «Guía de práctica clínica» sobre prevención del ictus sin que se haya evaluado su implementación. Nos planteamos investigar el seguimiento de dicha guía a través del análisis del control de factores de riesgo vascular y el tratamiento antitrombótico e hipolipemiante en pacientes con ictus isquémico agudo atendidos por neuról-ogos o internistas.Métodos: Estudio transversal descriptivo basado en los datos obtenidos de informes clínicos (factores de riesgo vascular, diagnóstico y tratamientos), cifras tensionales y analíticas de 203 pacientes con diagnóstico principal de ictus isquémico agudo que ingresaron para rehabilitación y cuidados en un hospital de media-larga estancia.Resultados: La edad media ± DE de los pacientes incluidos fue de 75 ± 10 años con un 56% de mujeres. Los factores de riesgo más frecuentes fueron hipertensión arterial (68%) y diabetes mellitus (40%). El 8,9% de los pacientes había recibido fibrinólisis por vía intravenosa. El...

show abstract

“…Combinando conocimiento (50%), tratamiento en conocidos (73%) y control en tratados (34%), só lo el 12% de todos los dislipidé micos adultos españ oles estarían controlados 13 (tabla 2). El grado de control de la dislipidemia en atenció n ambulatoria especializada fue del 50% en pacientes de alto o muy alto RCV 14 y del 50-60% en pacientes con aterotrombosis sintomá tica o alto riesgo de desarrollarla 15 , mientras que en atenció n primaria fue del 26% de los pacientes en prevenció n secundaria 16 . El estudio CIFARC, que evalú a el control simultá neo de los cinco principales factores de riesgo, obtiene un porcentaje de control global del 7% cuando se incluía la obesidad, y del 10% si se la excluía 14 .…”

Section: Prevalencia Y Grado De Control De La Dislipidemia Prevalenciaunclassified

Dislipidemias: un reto pendiente en prevención cardiovascular. Documento de consenso CEIPC/SEA

et al. 2011

View full text Add to dashboard Cite

Control de factores de riesgo y tratamiento de la aterotrombosis. Registro REACH España

Cited by 36 publications

References 22 publications

Metabolic syndrome in patients with peripheral arterial disease

Metabolic syndrome in patients with peripheral arterial disease

Implementation of clinical practice guidelines for acute ischaemic stroke in specialist care centres

Dislipidemias: un reto pendiente en prevención cardiovascular. Documento de consenso CEIPC/SEA

Contact Info

Product

Resources

About